Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis-Reference-Cited by-同舟云学术

Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis

Published:2012-05-22 Issue:5 Volume:35 Page:1119-1128
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Malagari Katerina,Pomoni Mary,Moschouris Hippocrates,Bouma Evanthia,Koskinas John,Stefaniotou Aspasia,Marinis Athanasios,Kelekis Alexios,Alexopoulou Efthymia,Chatziioannou Achilles,Chatzimichael Katerina,Dourakis Spyridon,Kelekis Nikolaos,Rizos Spyros,Kelekis Dimitrios

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00270-012-0394-0.pdf

Reference38 articles.

1. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35(5):1164–1171

2. Llovet JM, Real MI, Montana X et al (2002) Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359(9319):1734–1739

3. Lammer J, Malagari K, Vogl T et al (2010) PRECISION V Investigators. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33(1):41–52

4. Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46(3):474–481

5. Poon RN, Tso WK, Pang RWC et al (2007) A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5(9):1100–1108

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma;Pharmaceuticals;2024-08-11

2. Tumor diameter and enhancing capsule, as well as previous interventional treatments, as potential predictors of vascular lake phenomenon in hepatocellular carcinoma patients treated with drug-eluting beads transarterial chemoembolization;Journal of Clinical Imaging Science;2024-08-10

3. Transarterial Chemoembolization Treatment Paradigms for Hepatocellular Carcinoma;Cancers;2024-07-01

4. Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma;Journal of Clinical Medicine;2024-05-24

5. Combination of Doxorubicin and Antiangiogenic Agents in Drug-Eluting Beads: In Vitro Loading and Release Dynamics in View of a Novel Therapeutic Approach for Hepatocellular Carcinoma;CardioVascular and Interventional Radiology;2024-04-12